Literature DB >> 1155013

Vegetative innervation of the esophagus. III. Intraepithelial endings.

J Rodrigo, C J Hernández, M A Vidal, J A Pedrosa.   

Abstract

Intraepithelial fibers do occur in the mucosa of the esophagus, as demonstrated by the osmium tetroxide-zinc iodide method in cats and rhesus monkeys. The esophagus is divided into three parts, in order to study the penetration incidence, and the uppermost and the lowest show the greatest density of penetration, while in the middle portion only occasional fibers in small numbers are found. The specific characteristics observed in this type of fiber, such as their distribution along the wall of the esophagus, the levels reached by their endings within the mucous epithelium itself and this same epithelium considered as the specified destination of the endings, lead to the belief that they may be functionally regarded as structures of a sensory character.

Entities:  

Mesh:

Year:  1975        PMID: 1155013     DOI: 10.1159/000144444

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  17 in total

Review 1.  Functional heartburn: the stimulus, the pain, and the brain.

Authors:  R Fass; G Tougas
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Long-term experience of treating 185 patients with gastroesophageal reflux disease (GERD) by anti-reflux surgery respecting the functional-morphological restoration of the esophagus.

Authors:  R Horstmann; C Classen; S Röttgermann; M Langer; D Palmes
Journal:  Langenbecks Arch Surg       Date:  2005-11-18       Impact factor: 3.445

3.  Electrophysiological characterization of vagal afferents relevant to mucosal nociception in the rat upper oesophagus.

Authors:  J K M Lennerz; C Dentsch; N Bernardini; T Hummel; W L Neuhuber; P W Reeh
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

4.  Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces.

Authors:  Ricard Farré; Rita De Vos; Karel Geboes; Kristine Verbecke; Pieter Vanden Berghe; Inge Depoortere; Kathleen Blondeau; Jan Tack; Daniel Sifrim
Journal:  Gut       Date:  2007-02-01       Impact factor: 23.059

Review 5.  Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?

Authors:  Christos Triantos; Nikolaos Koukias; Georgios Karamanolis; Konstantinos Thomopoulos
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

6.  Distribution of immunoreactive substance P in opossum esophagus.

Authors:  J Christensen; T H Williams; J Jew; T M O'Dorisio
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.

Authors:  Tomasz Skoczylas; Harathi Yandrapu; Cezary Poplawski; Mazen Asadi; Grzegorz Wallner; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2014-03-09       Impact factor: 3.199

8.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

Review 9.  Nonerosive reflux disease: a pathophysiologic perspective.

Authors:  John D Long; Roy C Orlando
Journal:  Curr Gastroenterol Rep       Date:  2008-06

10.  Variation of the intercellular space in the esophageal epithelium in response to hydrochloridric acid infusion in patients with erosive esophagitis.

Authors:  Ricardo Tedeschi Matos; Rodrigo Schuler Honório; Elia Garcia Caldini; Claudio Lyoiti Hashimoto; Marcelo Alves Ferreira; Tomás Navarro-Rodriguez
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.